{"public_id":"cl_fc6b298a9988453e2b58b33ad8f9d027","status":"active","superseded_by_public_id":null,"corpus_id":41067945,"text":"After phosphodiesterase-5 inhibitors were removed from the Part D formulary, VA pharmacy use for these medications returned to 2005 levels.","confidence":0.96,"paper":{"corpus_id":41067945,"title":"Erectile Dysfunction Medication Use in Veterans Eligible for Medicare Part D","url":"https://sah.borca.ai/papers/41067945"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.96,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_596df4d98c0aa1ed0191ba20cdea0d46","name":"Part D formulary","description":"The list of drugs covered by Medicare Part D at a given time.","types":["coverage list"],"url":"https://sah.borca.ai/concepts/co_596df4d98c0aa1ed0191ba20cdea0d46"},{"public_id":"co_6a72143ab8b5b93b4fd946c1b381ebee","name":"VA pharmacies","description":"Pharmacies within the Veterans Affairs system that dispense covered medications.","types":["pharmacy"],"url":"https://sah.borca.ai/concepts/co_6a72143ab8b5b93b4fd946c1b381ebee"},{"public_id":"co_915b20f2ed3a47a2e1e2198002ee83f1","name":"phosphodiesterase-5 inhibitors","description":"A class of erectile dysfunction medications that inhibit phosphodiesterase type 5.","types":["medication class"],"url":"https://sah.borca.ai/concepts/co_915b20f2ed3a47a2e1e2198002ee83f1"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_fc6b298a9988453e2b58b33ad8f9d027"}